Health & Wellness
Tag: Clinical Trials
🧬 Revolution Medicines (RVMD): The Pancreatic Cancer Breakthrough That Created a 4x Stock
Pancreatic cancer has long been one of medicine's toughest challenges. Revolution Medicines may have changed the game. Daraxonrasib nearly doubled survival, achieved a remarkable 0.40 hazard ratio, and turned RVMD into one of biotech's biggest winners. Here's what patients and investors should know.
Pancreatic Cancer: Panned by Critics — but Science Is Finally Fighting Back
Pancreatic cancer is still brutal — but no longer hopeless. From surgery and chemotherapy to precision medicine and bold clinical trials, real progress is underway. 🧬⚔️
Acute Myeloid Leukemia: You May Not Feel Sick, But You Are
You can feel healthy while AML quietly takes over your bone marrow. A clear, human, and lightly funny guide to a very serious blood cancer.
U.S. Computational Biology: More Simulations, Less Culture, Will Boost Drug Discovery & Leave Animal Testing… Stranded
Computational biology is moving discovery from culture to compute. With AI models, multi-omics, and cloud HPC, the U.S. market is forecast to grow from ~$3.5B (2025) to ~$9.5B (2034). Expect faster target ID, better trial design, fewer animal tests—and more drugs reaching patients sooner.